Association of human DNA topoisomerase IIα with mitotic chromosomes in mammalian cells is independent of its catalytic activity

Experimental Cell Research

Volumn 252, Issue 1, 1999, Pages 50-62

  Mo, Yin Yuan ^a   Beck, William T ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Cell cycle; EGFP fusion; Expression; Subcellular localization; Topoisomerase II

Indexed keywords

DNA; DNA TOPOISOMERASE (ATP HYDROLYSING); GREEN FLUORESCENT PROTEIN; HYBRID PROTEIN;

AMINO ACID SUBSTITUTION; ARTICLE; CATALYSIS; CHROMOSOME; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME LOCALIZATION; HUMAN; HUMAN CELL; INTERPHASE; MITOSIS; PRIORITY JOURNAL; PROTEIN DNA BINDING; PROTEIN EXPRESSION;

EID: 0033543989     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1006/excr.1999.4616     Document Type: Article

References (47)

1. Wang J. C. DNA topoisomerases. Annu. Rev. Biochem. 65:1996;635-692.
2. D'Arpa P., Machlin P. S., Ratrie H. 3d., Rothfield N. F., Cleveland D. W., Earnshaw W. C. cDNA cloning of human DNA topoisomerase I: catalytic activity of a 67.7-kDa carboxyl-terminal fragment. Proc. Natl. Acad. Sci. USA. 85:1988;2543-2547.
3. Tsai-Pflugfelder M., Liu L. F., Liu A. A., Tewey K. M., Whang-Peng J., Knutsen T., Huebner K., Croce C. M., Wang J. C. Cloning and sequencing of cDNA encoding human DNA topoisomerase II and localization of the gene to chromosome region 17q21-22. Proc. Natl. Acad. Sci. USA. 85:1988;7177-7181.
4. Brill S. J., DiNArdo S., Voelkel-Meiman K., Sternglanz R. Need for DNA topoisomerase activity as a swivel for DNA replication for transcription of ribosomal RNA. Nature. 326:1987;414-416.
5. Culotta V., Sollner-Webb B. Sites of topoisomerase I action on X. laevis ribosomal chromatin: transcriptionally active rDNA has an approximately 200 bp repeating structure. Cell. 52:1988;585-597.
6. Nelson W. G., Liu L. F., Coffey D. S. Newly replicated DNA is associated with DNA topoisomerase II in cultured rat prostatic adenocarcinoma cells. Nature. 322:1986;187-189.
7. Yang L., Wold M. S., Li J. J., Kelly T. J., Liu L. F. Roles of DNA topoisomerase in simian virus 40 DNA replication in vitro. Proc. Natl. Acad. Sci. USA. 84:1987;950-954.
8. Adachi Y., Luke M., Laemmli U. K. Chromosome assembly in vitro: Topoisomerase II is required for condensation. Cell. 64:1991;137-148.
9. Holloway S. L. Sister chromatid separation in vivo and in vitro. Curr. Opin. Genet. Dev. 2:1995;243-248.
10. Hirano T., Mitchison T. J. Topoisomerase II does not play a scaffolding role in the organization of mitotic chromosomes assembled in Xenopus egg extracts. J. Cell Biol. 120:1993;601-612.
11. Roberge M., Th'ng J., Hamaguchi J., Bradbury E. M. The topoisomerase II inhibitor VM-26 induces marked changes in histone H1 kinase activity, histones H1 and H3 phosphorylation, and chromosome condensation in G2 phase and mitotic BHK cells. J. Cell Biol. 111:1990;1753-1762.
12. Rose D., Holm C. Meiosis-specific arrest revealed in DNA topoisomerase II mutants. Mol. Cell. Biol. 13:1993;3445-3455.
13. Subramanian D., Rosenstein B. S., Muller M. T. Ultraviolet-induced DNA damage stimulates topoisomerase I-DNA complex formation in vivo: Possible relationship with DNA repair. Cancer Res. 58:1998;976-984.
14. Liu L. F. DNA topoisomerase poisons as antitumor drugs. Annu. Rev. Biochem. 58:1989;351-375.
15. Jenkins J. R., Ayton P., Jones T., Davies S. L., Simmons D. L., Harris A. L., Sheer D., Hickson I. D. Isolation of cDNA clones encoding the beta isozyme of human DNA topoisomerase II and localisation of the gene to chromosome 3p24. Nucleic Acids Res. 20:1992;5587-5592.
16. Austin C. A., Marsh K. L. Eukaryotic DNA topoisomerase IIβ BioEssays. 20:1998;215-226.
17. Woessner R. D., Mattern M. R., Mirabelli C. K., Johnson R. K., Drake F. H. Proliferation- and cell cycle-dependent differences in expression of the 170 kilodalton and 180 kilodalton forms of topoisomerase II in NIH-3T3 cells. Cell Growth Differ. 2:1991;209-214.
18. Saitoh Y., Laemmli U. K. Metaphase chromosome structure: bands arise from a differential folding path of the highly AT-rich scaffold. Cell. 76:1994;609-622.
19. Taagepera S., Rao P. N., Drake F. H., Gorbsky G. J. DNA topoisomerase IIα is the major chromosome protein recognized by the mitotic phosphoprotein antibody MPM-2. Proc. Natl. Acad. Sci. USA. 90:1993;8407-8411.
20. Meyer K. N., Kjeldsen E., Straub T., Knudsen B. R., Hickson I. D., Kikuchi A., Kreipe H., Boege F. Cell cycle-coupled relocation of types I and II topoisomerases and modulation of catalytic enzyme activities. J. Cell Biol. 136:1997;775-788.
21. Mo Y-Y., Ameiss K. A., Beck W. T. Overexpression of human DNA Topoisomerase IIα by fusion to enhanced green fluorescent protein. BioTechniques. 25:1998;1052-1057.
22. Jordan M., Schallhorn A., Wurm F. M. Transfecting mammalian cells: optimization of critical parameters affecting calcium-phosphate precipitate formation. Nucleic Acids Res. 24:1996;596-601.
23. Mo Y. Y., Wang Q., Beck W. T. Down-regulation of topoisomerase IIα in CEM cells selected for merbarone resistance is associated with reduced expression of Sp3. Cancer Res. 57:1997;5004-5008.
24. Hann C., Evans D. L., Fertala J., Benedetti P., Bjornsti M. A., Hall D. J. Increased camptothecin toxicity induced in mammalian cells expressing Saccharomyces cerevisiae DNA topoisomerase I. J. Biol. Chem. 273:1998;8425-8433.
25. Boege F., Andersen A., Jensen S., Zeidler R., Kreipe H. Proliferation-associated nuclear antigen Ki-S1 is identical with topoisomerase IIα: Delination of a carboxyl-terminal epitope with peptide antibodies. Am. J. Pathol. 146:1995;1302-1308.
26. Friche E., Danks M. K., Schmidt C. A., Beck W. T. Decreased DNA topoisomerase II in daunorubicin-resistant Ehrlich ascites tumor cells. Cancer Res. 51:1991;4213-4218.
27. Jiang W., Hunter T. Analysis of cell-cycle profiles in transfected cells using a membrane-targeted GFP. BioTechniques. 24:1998;349-350.
28. Berger J. M., Gamblin S. J., Harrison S. C., Wang J. C. Structure and mechanism of DNA topoisomerase II. Nature. 379:1996;225-232.
29. Worland S. T., Wang J. C. Inducible overexpression, purification, and active site mapping of DNA topoisomerase II from the yeast Saccharomyces cerevisiae. J. Biol. Chem. 264:1989;4412-4416.
30. Osheroff N., Corbett A. H., Robinson M. J. Mechanism of action of topoisomerase II-targeted antineoplastic drugs. Adv. Pharmacol. 29B:1994;105-126.
31. Mirski S. E., Cole S. P. Cytoplasmic localization of a mutant M(r) 160,000 topoisomerase IIα is associated with the loss of putative bipartite nuclear localization signals in a drug-resistant human lung cancer cell line. Cancer Res. 55:1995;2129-2134.
32. Mirski S. E., Gerlach J. H., Cummings H. J., Zirngibl R., Greer P. A., Cole S. P. Bipartite nuclear localization signals in the C terminus of human topoisomerase IIα Exp. Cell Res. 237:1997;452-455.
33. Dingwall C., Laskey R. A. Nuclear targeting sequences - A consensus. Trends Biochem. Sci. 16:1991;478-481.
34. Vassetzky Y. S., Dang Q., Benedett I P., Gasser S. M. Topoisomerase II forms multimers in vitro: Effects of metals, beta-glycerophosphate, and phosphorylation of its C-terminal domain. Mol. Cell Biol. 14:1994;6962-6974.
35. Rattner J. B., Hendzel M. J., Furbee C. S., Muller M. T., Bazett-Jones D. P. Topoisomerase IIα is associated with the mammalian centromere in a cell cycle- and species-specific manner and is required for proper centromere/kinetochore structure. J. Cell Biol. 134:1996;1097-1107.
36. Bojanowski K., Maniotis A. J., Plisov S., Larsen A. K., Ingber D. E. DNA topoisomerase II can drive changes in higher order chromosome architecture without enzymatically modifying DNA. J. Cell Biochem. 69:1998;127-142.
37. Swedlow J. R., Sedat J. W., Agard D. A. Multiple chromosomal populations of topoisomerase II detected in vivo by time-lapse, three-dimensional wide-field icroscopy. Cell. 73:1993;97-108.
38. Grue P., Graer A., Sehested M., Jensen P. B., Uhse A., Straub T., Ness W., Boege F. Essential mitotic functions of DNA topoisomerase IIα are not adopted by topoisomerase IIβ in human H69 cells. J. Biol. Chem. 273:1998;33660-33666.
39. Goswami P. C., Roti Roti J. L., Hunt C. R. The cell cycle-coupled expression of topoisomerase II alpha during S phase is regulated by mRNA stability and is disrupted by heat shock or ionizing radiation. Mol. Cell Biol. 16:1996;1500-1508.
40. Heck M. M., Hittelman W. N., Earnshaw W. C. Differential expression of DNA topoisomerases I and II during the eukaryotic cell cycle. Proc. Natl. Acad. Sci. USA. 85:1988;1086-1090.
41. Kinura K., Hirano M., Kobayashi R., Hirano T. Phosphorylation and activation of 13S condensin by cdc2 in vitro. Science. 282:1998;487-490.
42. Beck W. T. DNA topoisomerases and tumor cell resistance to their inhibitors. Shilsky R., Milano G., Ratain M. Principles of Cancer Drug Pharmacology. 1996;487-501 Dekker, New York.
43. Nitiss J. L., Beck W. T. . Eur. J. Cancer. 32A:1996;958-966.
44. Vassetzky Y. S., Alghisi G. C., Gasser S. M. DNA topoisomerase II mutations and resistance to anti-tumor drugs. Bioessays. 17:1995;767-774.
45. Hsiung Y., Jannatipour M., Rose A., McMahon J., Duncan D., Nitiss J. L. Functional expression of human topoisomerase IIα in yeast: Mutations at amino acids 450 or 803 of topoisomerase IIα result in enzymes that can confer resistance to anti-topoisomerase II agents. Cancer Res. 56:1996;91-99.
46. Wells N. J., Addison C. M., Fry A. M., Ganapathi R., Hickson I. D. Serine 1524 is major site of phosphorylation on human topoisomerase IIα protein in vivo and is a substrate for casein kinase II in vitro. J. Biol. Chem. 269:1994;29746-29751.
47. Wells N. J., Fry A. M., Guano F., Norbury C., Hickson I. D. Cell cycle phase-specific phosphorylation of human topoisomerase IIα: Evidence of a role for protein kinase C. J. Biol. Chem. 270:1995;28357-28363.